Our results from an ongoing study with a newly developed mouse carrying liver-specific deletion of nSMase2 (currently prepared for a separate publication) provide evidence for a similar role of nSMase2 in obesity-induced hepatic IR. This evidence concerns the gene SMPD3 and Hepatitis.